{"product_id":"healthcare-example-product-1","title":"Dual Control Fat Burn Pen","description":"\u003cp\u003e\u003cstrong\u003eUnderstanding Tirz:\u003c\/strong\u003e\u003cbr\u003eThis product is a reusable pen system, which uses refill cartridges for precise and convenient delivery.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eProduct Strength:\u003c\/strong\u003e 30mg per 3ml cartridge.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eStorage: \u003c\/span\u003e\u003c\/strong\u003e\u003cstrong\u003e\u003cspan\u003eKeep refrigerated\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e between \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003e2–8 °C (36–46 °F)\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e to maintain potency and stability.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWhat It Is\u003c\/strong\u003e\u003cbr\u003eTirzepatide is a once-weekly injectable prescription medication that represents a breakthrough in metabolic health. It is the first and only dual GIP and GLP-1 receptor agonist, designed to address two critical natural hormones that regulate blood sugar and appetite. It is marketed as Zepbound for chronic weight management and Mounjaro for type 2 diabetes.\u003c\/p\u003e\n\u003cp\u003e\u003cspan style=\"text-decoration: underline;\"\u003e\u003cstrong\u003eHow It Works\u003c\/strong\u003e\u003c\/span\u003e\u003cbr\u003eUnlike single-hormone agonists, tirzepatide’s dual-action mechanism targets the body’s innate systems to drive results:\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eGLP-1 Receptor Agonism:\u003c\/strong\u003e Signals the brain to feel full (satiety) and slows gastric emptying, helping you feel fuller for longer.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eGIP Receptor Agonism:\u003c\/strong\u003e Enhances the body’s ability to break down fat and improves insulin sensitivity, complementing the weight-loss effects.\u003c\/p\u003e\n\u003cp\u003e\u003cspan style=\"text-decoration: underline;\"\u003e\u003cstrong\u003eKey Benefits for Weight Loss \u0026amp; Metabolic Health\u003c\/strong\u003e\u003c\/span\u003e\u003cbr\u003eClinical trials, including the landmark SURMOUNT and SURMOUNT-5 studies, have demonstrated the superior efficacy of tirzepatide:\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSubstantial Weight Reduction:\u003c\/strong\u003e Patients achieved significant results after 72 weeks. At the maximum maintenance dose of 15 mg, participants lost an average of 23.6 kg (52.0 lb) . Some trials reported total body weight reductions of 20–26.6% when combined with diet and exercise, outperforming single-agonist medications in head-to-head trials.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eAppetite Suppression:\u003c\/strong\u003e By activating GLP-1 receptors in the brain and slowing gastric emptying, tirzepatide significantly reduces hunger and lowers calorie intake.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eImproved Metabolic Health:\u003c\/strong\u003e Beyond the scale, tirzepatide enhances insulin sensitivity, stabilizes blood sugar, and reduces key risk factors such as waist circumference, blood pressure, and lipid levels, contributing to overall cardiovascular health.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSustained Long-Term Results: \u003c\/strong\u003eLong-term data (3-year outcomes) show sustained weight loss (averaging 22.9%) with lifestyle interventions. Additionally, it reduced the risk of progressing to type 2 diabetes by 94% in at-risk individuals.\u003cspan style=\"text-decoration: underline;\"\u003e\u003cstrong\u003e\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan style=\"text-decoration: underline;\"\u003e\u003cstrong\u003ePossible Side Effects \u0026amp; Warnings\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCommon Side Effects:\u003c\/strong\u003e Nausea, diarrhea, vomiting, constipation, abdominal pain, heartburn, and fatigue. These are often most pronounced when initiating therapy or increasing the dose.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSevere Side Effects:\u003c\/strong\u003e Potential for severe stomach pain (indicating possible gallbladder issues), severe nausea\/vomiting, and signs of low blood sugar (hypoglycemia), particularly if used with insulin or sulfonylureas.\u003c\/p\u003e\n\u003cp\u003e\u003cspan style=\"text-decoration: underline;\"\u003e\u003cstrong\u003eBlack Box Warning: \u003c\/strong\u003e\u003c\/span\u003eTirzepatide carries a black box warning regarding the potential risk of thyroid C-cell tumors. It is contraindicated in patients with a personal or family history of Medullary Thyroid Carcinoma (MTC) or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDisclaimer: This information is for general knowledge and educational purposes only and does not constitute medical advice. Tirzepitide is a  prescription medication that should only be used under the guidance of a licensed healthcare professional. Always follow your prescribed dosage and administration instructions\u003c\/strong\u003e\u003c\/p\u003e","brand":"All Peptides","offers":[{"title":"Default Title","offer_id":51859604373786,"sku":null,"price":2550.0,"currency_code":"ZAR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0987\/8926\/1594\/files\/Your-First-3-Months-on-Semaglutide-How-Much-Weight-Can-You-Lose-with-Ozempic-Florida-Surgery-And-Weight-Loss-Center-1024x719.jpg?v=1779276565","url":"https:\/\/allpeptides.co.za\/products\/healthcare-example-product-1","provider":"All Peptides","version":"1.0","type":"link"}